| J9271 | Injection, pembrolizumab, 1 mg | 26,800 | $40 | $938K |
| J0897 | Injection, denosumab, 1 mg | 9,540 | $20 | $171.7K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 3,830 | $40 | $137.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 560 | $90 | $51.1K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 600 | $80 | $50.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 360 | $110 | $38.2K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 270 | $140 | $35.9K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 110 | $140 | $14.7K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 50 | $180 | $8.4K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 150 | $50 | $7.7K |